Literature DB >> 15831077

Heparan sulfate proteoglycans: key players in cartilage biology.

Mary C Farach-Carson1, Jacqueline T Hecht, Daniel D Carson.   

Abstract

The extracellular matrix (ECM) plays a fundamental role in skeletal patterning and formation of the vertebrate skeleton. This review focuses on the fundamental roles associated with heparan sulfate (HS) proteoglycans in the ECM during cartilage development, which include regulation of gene expression, presentation of growth factors, establishment of morphogen gradients, and modulation of blood homeostasis. The importance of enzymes involved in biosynthesis and assembly of heparan sulfate is also discussed. Finally, the current evidence for functions of individual HS proteoglycans and biosynthetic enzymes based upon human genetic mutation associations with disease and genetic manipulation in transgenic mice is presented. These findings highlight the important role played by HS proteoglycans, such as perlecan, in cartilage development and skeletal growth.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15831077     DOI: 10.1615/critreveukaryotgeneexpr.v15.i1.30

Source DB:  PubMed          Journal:  Crit Rev Eukaryot Gene Expr        ISSN: 1045-4403            Impact factor:   1.807


  20 in total

1.  Stimulation of Superficial Zone Protein/Lubricin/PRG4 by Transforming Growth Factor-β in Superficial Zone Articular Chondrocytes and Modulation by Glycosaminoglycans.

Authors:  Araceli Cuellar; A Hari Reddi
Journal:  Tissue Eng Part A       Date:  2014-12-23       Impact factor: 3.845

2.  Intraarticular injection of heparin-binding insulin-like growth factor 1 sustains delivery of insulin-like growth factor 1 to cartilage through binding to chondroitin sulfate.

Authors:  Rachel E Miller; Alan J Grodzinsky; Kiersten Cummings; Anna H K Plaas; Ada A Cole; Richard T Lee; Parth Patwari
Journal:  Arthritis Rheum       Date:  2010-12

3.  About the importance of being desulfated.

Authors:  Richa Khatri; Ernestina Schipani
Journal:  Genes Dev       Date:  2008-10-15       Impact factor: 11.361

4.  Biomaterials-Based Strategies for the Engineering of Mechanically Active Soft Tissues.

Authors:  Zhixiang Tong; Xinqiao Jia
Journal:  MRS Commun       Date:  2012-06-01       Impact factor: 2.566

5.  Hypoxia increases VEGF-A production by prostate cancer and bone marrow stromal cells and initiates paracrine activation of bone marrow endothelial cells.

Authors:  Caroline Muir; Leland W K Chung; Daniel D Carson; Mary C Farach-Carson
Journal:  Clin Exp Metastasis       Date:  2006-07-07       Impact factor: 5.150

6.  A novel peptide sequence in perlecan domain IV supports cell adhesion, spreading and FAK activation.

Authors:  Mary C Farach-Carson; Anissa J Brown; Megan Lynam; Jeffrey B Safran; Daniel D Carson
Journal:  Matrix Biol       Date:  2007-10-10       Impact factor: 11.583

7.  Perlecan domain I-conjugated, hyaluronic acid-based hydrogel particles for enhanced chondrogenic differentiation via BMP-2 release.

Authors:  Amit K Jha; Weidong Yang; Catherine B Kirn-Safran; Mary C Farach-Carson; Xinqiao Jia
Journal:  Biomaterials       Date:  2009-09-23       Impact factor: 12.479

Review 8.  Multifunctionality of extracellular and cell surface heparan sulfate proteoglycans.

Authors:  Catherine Kirn-Safran; Mary C Farach-Carson; Daniel D Carson
Journal:  Cell Mol Life Sci       Date:  2009-07-24       Impact factor: 9.261

9.  Heparanase expression and activity influences chondrogenic and osteogenic processes during endochondral bone formation.

Authors:  A J Brown; M Alicknavitch; S S D'Souza; T Daikoku; C B Kirn-Safran; D Marchetti; D D Carson; M C Farach-Carson
Journal:  Bone       Date:  2008-06-06       Impact factor: 4.398

10.  S100A8 and S100A9 in experimental osteoarthritis.

Authors:  Hala Zreiqat; Daniele Belluoccio; Margaret M Smith; Richard Wilson; Lynn A Rowley; Katie Jones; Yogambha Ramaswamy; Thomas Vogl; Johannes Roth; John F Bateman; Christopher B Little
Journal:  Arthritis Res Ther       Date:  2010-01-27       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.